rs200782847
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_004484.4(GPC3):c.1032+9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000666 in 1,181,505 control chromosomes in the GnomAD database, including 3 homozygotes. There are 247 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00065 ( 0 hom., 27 hem., cov: 22)
Exomes 𝑓: 0.00067 ( 3 hom. 220 hem. )
Consequence
GPC3
NM_004484.4 intron
NM_004484.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.211
Genes affected
GPC3 (HGNC:4451): (glypican 3) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant X-133753473-G-A is Benign according to our data. Variant chrX-133753473-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 415275.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-133753473-G-A is described in Lovd as [Likely_benign].
BS2
High Hemizygotes in GnomAd4 at 27 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPC3 | NM_004484.4 | c.1032+9C>T | intron_variant | ENST00000370818.8 | NP_004475.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPC3 | ENST00000370818.8 | c.1032+9C>T | intron_variant | 1 | NM_004484.4 | ENSP00000359854.3 |
Frequencies
GnomAD3 genomes AF: 0.000655 AC: 73AN: 111474Hom.: 0 Cov.: 22 AF XY: 0.000802 AC XY: 27AN XY: 33662
GnomAD3 genomes
AF:
AC:
73
AN:
111474
Hom.:
Cov.:
22
AF XY:
AC XY:
27
AN XY:
33662
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00102 AC: 186AN: 182812Hom.: 1 AF XY: 0.000919 AC XY: 62AN XY: 67458
GnomAD3 exomes
AF:
AC:
186
AN:
182812
Hom.:
AF XY:
AC XY:
62
AN XY:
67458
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000667 AC: 714AN: 1070031Hom.: 3 Cov.: 29 AF XY: 0.000645 AC XY: 220AN XY: 340823
GnomAD4 exome
AF:
AC:
714
AN:
1070031
Hom.:
Cov.:
29
AF XY:
AC XY:
220
AN XY:
340823
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000655 AC: 73AN: 111474Hom.: 0 Cov.: 22 AF XY: 0.000802 AC XY: 27AN XY: 33662
GnomAD4 genome
AF:
AC:
73
AN:
111474
Hom.:
Cov.:
22
AF XY:
AC XY:
27
AN XY:
33662
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Wilms tumor 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Simpson-Golabi-Behmel syndrome type 1;CN033288:Wilms tumor 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 19, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at